Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
BIOSU BIOPLUS ACQUISITION CORP UNIT 1 CL A & 1/2 WT EXP
10.3200.0000.00%
Trading Session
01/31 09:30 ET
High
0.000
Open
0.000
Turnover
0.00
Low
0.000
Pre Close
10.320
Volume
0.00
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Short Interest in BioPlus Acquisition Corp. (NASDAQ:BIOS) Decreases By 14.3%
BioPlus Acquisition Corp. (NASDAQ:BIOS – Get Rating) was the recipient of a large decrease in short interest during the month of December. As of December 30th, there was short interest totalling 1,20
Short Interest in BioPlus Acquisition Corp. (NASDAQ:BIOS) Decreases By 53.3%
BioPlus Acquisition Corp. (NASDAQ:BIOS – Get Rating) was the target of a large drop in short interest in December. As of December 15th, there was short interest totalling 1,400 shares, a drop of 53.
BioPlus Acquisition (NASDAQ:BIOSU) Stock Price Down 0.1%
BioPlus Acquisition Corp. (NASDAQ:BIOSU – Get Rating) fell 0.1% on Wednesday . The stock traded as low as $10.19 and last traded at $10.19. 112 shares changed hands during mid-day trading, a decline
Centiva Capital LP Grows Stake in BioPlus Acquisition Corp. (NASDAQ:BIOS)
Centiva Capital LP lifted its position in BioPlus Acquisition Corp. (NASDAQ:BIOS – Get Rating) by 3.3% during the second quarter, according to the company in its most recent filing with the Securiti
BioPlus Acquisition Corp. Announces Pricing of Upsized $200,000,000 Initial Public Offering
NEW YORK, Dec. 06, 2021 (GLOBE NEWSWIRE) -- BioPlus Acquisition Corp. (the "Company") announced today that it priced its upsized initial public offering of 20,000,000 units at $10.00 per unit. The u
BioPlus Acquisition Shares Will Open For Quote At 10:10 a.m. EST, Expected To Open For Trade After 10:20 a.m. EST; IPO Priced $10/Unit
BioPlus Acquisition Corp. (the "Company") announced today that it priced its upsized initial public offering of 20,000,000 units at $10.00 per unit. The units will be listed on the Nasdaq Global Marke
BioPlus Acquisition Prices Upsized IPO at $10 Per Unit
05:20 AM EST, 12/03/2021 (MT Newswires) -- Blank-check firm BioPlus Acquisition on Thursday priced an initial public offering of 20 million units, increased from the prior size of 18 million units, a
No More
Company Overview
More
BioPlus Acquisition Corp. is an early stage blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. It focuses on identifying an opportunity in the life sciences industry. The company was founded on February 11, 2021 and is headquartered in New York, NY.
CEO： Mr. Ross Haghighat
Market： NASDAQ
Listing Date： 12/03/2021
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet